404 related articles for article (PubMed ID: 23375620)
1. Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome.
Marie I; Josse S; Decaux O; Diot E; Landron C; Roblot P; Jouneau S; Hatron PY; Hachulla E; Vittecoq O; Menard JF; Jouen F; Dominique S
Eur J Intern Med; 2013 Jul; 24(5):474-9. PubMed ID: 23375620
[TBL] [Abstract][Full Text] [Related]
2. Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome.
Marie I; Josse S; Hatron PY; Dominique S; Hachulla E; Janvresse A; Cherin P; Mouthon L; Vittecoq O; Menard JF; Jouen F
Arthritis Care Res (Hoboken); 2013 May; 65(5):800-8. PubMed ID: 23203765
[TBL] [Abstract][Full Text] [Related]
3. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.
Marie I; Hatron PY; Dominique S; Cherin P; Mouthon L; Menard JF
Arthritis Rheum; 2011 Nov; 63(11):3439-47. PubMed ID: 21702020
[TBL] [Abstract][Full Text] [Related]
4. Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome.
Marie I; Josse S; Decaux O; Dominique S; Diot E; Landron C; Roblot P; Jouneau S; Hatron PY; Tiev KP; Vittecoq O; Noel D; Mouthon L; Menard JF; Jouen F
Autoimmun Rev; 2012 Aug; 11(10):739-45. PubMed ID: 22326685
[TBL] [Abstract][Full Text] [Related]
5. Interstitial lung disease in polymyositis and dermatomyositis.
Marie I; Hachulla E; Chérin P; Dominique S; Hatron PY; Hellot MF; Devulder B; Herson S; Levesque H; Courtois H
Arthritis Rheum; 2002 Dec; 47(6):614-22. PubMed ID: 12522835
[TBL] [Abstract][Full Text] [Related]
6. Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.
Hervier B; Devilliers H; Stanciu R; Meyer A; Uzunhan Y; Masseau A; Dubucquoi S; Hatron PY; Musset L; Wallaert B; Nunes H; Maisonobe T; Olsson NO; Adoue D; Arlet P; Sibilia J; Guiguet M; Lauque D; Amoura Z; Hachulla E; Hamidou M; Benveniste O
Autoimmun Rev; 2012 Dec; 12(2):210-7. PubMed ID: 22771754
[TBL] [Abstract][Full Text] [Related]
7. Outcome of anti-PL12 positive patients with antisynthetase syndrome.
Marie I; Josse S; Decaux O; Dominique S; Landron C; Roblot P; Jouneau S; Vittecoq O; Jouen F
Presse Med; 2013 Jun; 42(6 Pt 1):e153-8. PubMed ID: 23428662
[TBL] [Abstract][Full Text] [Related]
8. Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies.
Shi J; Li S; Yang H; Zhang Y; Peng Q; Lu X; Wang G
J Rheumatol; 2017 Jul; 44(7):1051-1057. PubMed ID: 28461650
[TBL] [Abstract][Full Text] [Related]
9. Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody.
Marie I; Hatron PY; Dominique S; Cherin P; Mouthon L; Menard JF; Levesque H; Jouen F
Semin Arthritis Rheum; 2012 Jun; 41(6):890-9. PubMed ID: 22078416
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
Zhan X; Yan W; Wang Y; Li Q; Shi X; Gao Y; Ye Q
BMC Pulm Med; 2021 Feb; 21(1):57. PubMed ID: 33579248
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of patients with polymyositis/ dermatomyositis and anti-PM-Scl antibody.
Marie I; Lahaxe L; Benveniste O; Delavigne K; Adoue D; Mouthon L; Hachulla E; Constans J; Tiev K; Diot E; Levesque H; Boyer O; Jouen F
Br J Dermatol; 2010 Feb; 162(2):337-44. PubMed ID: 19845665
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors of interstitial lung disease progression at sequential HRCT in anti-synthetase syndrome.
Liu H; Xie S; Liang T; Ma L; Sun H; Dai H; Wang C
Eur Radiol; 2019 Oct; 29(10):5349-5357. PubMed ID: 30919069
[TBL] [Abstract][Full Text] [Related]
13. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
[TBL] [Abstract][Full Text] [Related]
14. Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies.
Fukamatsu H; Hirai Y; Miyake T; Kaji T; Morizane S; Yokoyama E; Hamada T; Oono T; Koyama Y; Norikane S; Iwatsuki K
J Dermatol; 2019 Oct; 46(10):886-897. PubMed ID: 31418479
[TBL] [Abstract][Full Text] [Related]
15. [Antisynthetase syndrome: a report of four cases and literature review].
Frikha F; Saidi N; Snoussi M; Ben Salah R; Ben Ayed M; Daoud E; Hentati Y; Makni S; Mnif Z; Boudawara T; Masmoudi H; Bahloul Z
Rev Pneumol Clin; 2012 Dec; 68(6):351-60. PubMed ID: 23062471
[TBL] [Abstract][Full Text] [Related]
16. Mechanic's hands in a woman with undifferentiated connective tissue disease and interstitial lung disease--anti-PL7 positive antisynthetase syndrome: a case report.
De Langhe E; Lenaerts J; Bossuyt X; Westhovens R; Wuyts WA
J Med Case Rep; 2015 Apr; 9():82. PubMed ID: 25888844
[TBL] [Abstract][Full Text] [Related]
17. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase.
Hirakata M; Suwa A; Takada T; Sato S; Nagai S; Genth E; Song YW; Mimori T; Targoff IN
Arthritis Rheum; 2007 Apr; 56(4):1295-303. PubMed ID: 17393393
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome.
Zamora AC; Hoskote SS; Abascal-Bolado B; White D; Cox CW; Ryu JH; Moua T
Respir Med; 2016 Sep; 118():39-45. PubMed ID: 27578469
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine in anti-Jo1-positive patients with corticosteroid-refractory interstitial lung disease.
Cavagna L; Caporali R; Abdì-Alì L; Dore R; Meloni F; Montecucco C
J Rheumatol; 2013 Apr; 40(4):484-92. PubMed ID: 23418387
[TBL] [Abstract][Full Text] [Related]
20. Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.
Stanciu R; Guiguet M; Musset L; Touitou D; Beigelman C; Rigolet A; Costedoat-Chalumeau N; Allenbach Y; Hervier B; Dubourg O; Maisonobe T; Charuel JL; Behin A; Herson S; Amoura Z; Grenier P; Benveniste O
J Rheumatol; 2012 Sep; 39(9):1835-9. PubMed ID: 22859355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
